# Monosialoganglioside(GM1) Preventing Neurotoxicity Induced by Cisplatin Contained Chemotherapy in NSCLC Patients

> **NCT01882621** · PHASE3 · UNKNOWN · sponsor: **Sun Yat-sen University** · enrollment: 300 (estimated)

## Conditions studied

- Non-small Cell Lung Cancer

## Interventions

- **DRUG:** Monosialoganglioside(GM1)
- **DRUG:** normal saline

## Key facts

- **NCT ID:** NCT01882621
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-10
- **Primary completion:** 2016-08
- **Final completion:** 2016-08
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2016-06-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01882621

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01882621, "Monosialoganglioside(GM1) Preventing Neurotoxicity Induced by Cisplatin Contained Chemotherapy in NSCLC Patients". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT01882621. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*